group-sequential-methods

Plan and implement group sequential designs with alpha-spending and futility boundaries using simtrial and gsDesign2 simulations.

9|1|Updated Jan 10, 2026
One-click install
npx skills add https://github.com/choxos/BiostatAgent --skill group-sequential-methods
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: group-sequential-methods
Source: https://github.com/choxos/BiostatAgent/tree/main/plugins/clinical-trial-simulation/skills/group-sequential-methods
Command: npx skills add https://github.com/choxos/BiostatAgent --skill group-sequential-methods

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

Design and evaluation of group sequential trials with interim analyses, managing alpha spending and futility boundaries to preserve statistical properties and efficiency.

Core Features & Use Cases

  • Designs for group sequential trials with predefined analysis timing
  • Alpha-spending strategies (OBF, Pocock, HSD) and their practical trade-offs
  • Simulation-based validation using simtrial and gsDesign2 to compare stopping boundaries
  • Use cases include regulatory submissions, DSMB planning, and rapid decision-making in trials

Quick Start

Run a GS simulation with simtrial and gsDesign2 to illustrate how boundaries affect early stopping

Frequently Asked Questions about group-sequential-methods

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I design group sequential trials with interim analyses using R?

Design group sequential trials by applying alpha-spending strategies like OBF, Pocock, and HSD, and validating stopping boundaries through simulation using R packages simtrial and gsDesign2.

What is the difference between OBF and Pocock alpha-spending boundaries?

OBF boundaries are highly conservative at early interim analyses, while Pocock applies a constant boundary across all looks. Both strategies preserve overall alpha while managing early stopping trade-offs in group sequential designs.

How do I validate futility boundaries for a clinical trial simulation?

Validate futility boundaries by running trial simulations with simtrial and gsDesign2 to compare stopping rules across multiple analyses, verifying boundary performance and information fractions before regulatory submission.

Can I use gsDesign2 and simtrial for DSMB planning and regulatory submissions?

Yes, gsDesign2 and simtrial support DSMB planning and regulatory submissions by providing simulation-based validation of stopping rules and alpha-spending boundaries for rapid decision-making in clinical trials.

Do I need prior experience with R packages to implement interim analysis boundaries?

Yes, implementing interim analysis boundaries requires familiarity with R packages like simtrial and gsDesign2 to properly configure information fractions, alpha-spending strategies, and simulation-based validation.

What are the limitations of simulation-based validation for group sequential designs?

Simulation-based validation requires accurate specification of information fractions and boundary parameters. Complex group sequential designs with multiple futility boundaries may demand extensive computational resources to simulate stopping rules accurately.